FDA greenlights 3D-printed cervical spacer system

An established company in the spinal device market has added a 3D-printed vertebral spacer to its line of FDA-cleared products.

Lewisville, Texas-based Orthofix Medical says its latest offering allows neck bone to grow into and through the spacer, helping the patient’s cervical vertebrae to fuse following the spacer’s surgical insertion as a lasting therapy for herniated or degenerative discs.

Called the Construx Mini Ti (for titanium) spacer system, the newly approved technology follows several similar products in Orthofix’s line to win FDA’s OK.

The company says the Mini Ti features 3D-printed porous titanium with macro, micro and nanoscale surface features.

Full announcement here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.